| 英文别名 |
Naltrexone;17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one;Naltrexone (base, anhydrous);Naltrexone solution;(5α)-17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one;celupan;Depotrex;en1639;en1939;Naltrel;NeMexin;trexan;Trexonil;Um-792;C07253;Q409587;SPBio_002071;cid_5485201;Naltrexon;(5-alpha)-17-(Cyclopropylmethyl-4,5-epoxy-3,14-dihydroxy morphinan-6-one;ReVia;DTXSID4046313;Tox21_112007_1;(5alpha)-17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one;US9107954, naltrexone;AB00174152-14;Addex-1000;SCHEMBL34681;SMP1_000206;PTI-555;NALTREXONE COMPONENT OF CONTRAVE;BDBM60212;BRD-K88172511-003-20-3;CS-0880;Vivitrex;NALTREXONE (MART.);Morphinan-6-one, 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-, (5alpha)-;Morphinan-6-one, 17-(cyclopropylmethyl)-4,5-alpha-epoxy-3,14-dihydroxy-;NALTREXONE [USAN];HS-0002;BRD-K88172511-310-03-8;NCGC00162274-02;CHEMBL19019;(1S,5R,13R,17S)-4-(cyclopropylmethyl)-10,17-dihydroxy-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7(18),8,10-trien-14-one;DA-55992;NALTREXONE [MART.];(4R,4As,7aR)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one;HMS2089O11;BDBM50000787;BIDD:GT0405;Tox21_112007;CCRIS 3506;N07BB04;D05113;AC-36726;Naltrexona (INN-Spanish);PDSP2_000847;Naltrexonum [INN-Latin];Naltrexona [INN-Spanish];BRD-K88172511-003-21-1;NALTREXONE [WHO-DD];EINECS 240-649-9;Prestwick2_000116;Naltrexone [USAN:INN:BAN];BCP07022;Naltrexonum;NCGC00024427-05;NALTREXONE (USP-RS);(4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one;AKOS015994596;BPBio1_000146;3,14-dihydroxy-17-(cyclopropylmethyl)-4,5alpha-epoxymorphinan-6-one;(4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-bis(oxidanyl)-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one;hydrochloride;NCGC00024427-03;UNII-5S6W795CQM;(4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one;hydrochloride;Naltrexona;NCGC00024427-04;NALTREXONE [HSDB];NSC-758439;NALTREXONE [ORANGE BOOK];BRD-K88172511-003-19-5;EN300-19748946;Prestwick0_000116;N-Cyclopropylmethyl-14-hydroxydihydromorphinone;NALTREXONE [INN];Prestwick3_000116;BRN 3596648;HSDB 6750;17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxmorphinan-6-one, (5.alpha.)-;Vivitrol (TN);N-Cyclopropylmethylnoroxymorphone;16590-41-3;BSPBio_000132;NALTREXONE [MI];NALTREXONE [VANDF];Naltrexone (1.0 mg/mL in Methanol);Vivitrol;NALTREXONE [USP-RS];HY-76711;EN-1639A FREE BASE;MFCD00242996;Morphinan-6-one, 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-, (5.alpha.)-;Naltrexone base anhydrous;DB00704;NS00009185;(-)naltrexone;(-)-Naltrexone;(4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,3,4,4a,5,6-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7(7aH... |
